These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15389242)

  • 21. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.
    Romano S; Di Mauro M; Fratini S; Guarracini L; Guarracini F; Poccia G; Penco M
    Cardiovasc Diabetol; 2010 Dec; 9():89. PubMed ID: 21162718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.
    Aspromonte N; Feola M; Scardovi AB; Coletta C; D'Eri A; Giovinazzo P; Carunchio A; Chiera A; Fanelli R; Di Giacomo T; Ricci R; Ceci V; Milani L; Valle R
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):406-13. PubMed ID: 16721202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure-a comparison with brain natriuretic peptide.
    Vinereanu D; Lim PO; Frenneaux MP; Fraser AG
    Eur J Heart Fail; 2005 Jun; 7(4):512-9. PubMed ID: 15921788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative plasma B-type natriuretic peptide (BNP) identifies abnormal transthoracic echocardiography in elderly patients with traumatic hip fracture.
    Pili-Floury S; Ginet M; Saunier L; Besch G; Bartholin F; Chopard R; Boillot A; Mebazaa A; Samain E
    Injury; 2012 Jun; 43(6):811-6. PubMed ID: 22029947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes of left ventricular systolic and diastolic function and the diagnostic value of B-type natriuretic peptide in patients with sepsis].
    Lin X; Jiang X; Cheng Q; Liu C; Zhang X
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(11):816-20. PubMed ID: 24854747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy].
    Elbl L; Vásová I; Navrátil M; Vorlícek J; Malásková L; Spinar J
    Vnitr Lek; 2006 Jun; 52(6):563-70. PubMed ID: 16871759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation.
    Kerr AJ; Raffel OC; Whalley GA; Zeng I; Stewart RA
    Eur Heart J; 2008 Feb; 29(3):363-70. PubMed ID: 18202251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of acoustic cardiography to resolve ambiguous values of B-type natriuretic Peptide levels in patients with suspected heart failure.
    Zuber M; Kipfer P; Attenhofer Jost CH
    Am J Cardiol; 2007 Sep; 100(5):866-9. PubMed ID: 17719335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of phonoelectrocardiographic left ventricular systolic time intervals and B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction.
    Moyers B; Shapiro M; Marcus GM; Gerber IL; McKeown BH; Vessey JC; Jordan MV; Huddleston M; Foster E; Chatterjee K; Michaels AD
    Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):89-97. PubMed ID: 17593176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction.
    Murtagh G; Dawkins IR; O'Connell R; Badabhagni M; Patel A; Tallon E; O'Hanlon R; Ledwidge MT; McDonald KM
    Eur J Heart Fail; 2012 May; 14(5):480-6. PubMed ID: 22416086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.
    Heidenreich PA; Gubens MA; Fonarow GC; Konstam MA; Stevenson LW; Shekelle PG
    J Am Coll Cardiol; 2004 Mar; 43(6):1019-26. PubMed ID: 15028361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical criteria and biochemical markers for the detection of systolic dysfunction.
    Yamamoto K; Burnett JC; Bermudez EA; Jougasaki M; Bailey KR; Redfield MM
    J Card Fail; 2000 Sep; 6(3):194-200. PubMed ID: 10997744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
    Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy.
    Talvani A; Rocha MO; Cogan J; Maewal P; de Lemos J; Ribeiro AL; Teixeira MM
    Mem Inst Oswaldo Cruz; 2004 Oct; 99(6):645-9. PubMed ID: 15558179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the usefulness of Doppler-derived deceleration time versus plasma brain natriuretic peptide to predict left ventricular remodeling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction.
    Cerisano G; Pucci PD; Valenti R; Boddi V; Migliorini A; Tommasi MS; Raspanti S; Parodi G; Antoniucci D
    Am J Cardiol; 2005 Apr; 95(8):930-4. PubMed ID: 15820157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of tissue Doppler echocardiography in the emergency diagnosis of decompensated heart failure with preserved left ventricular systolic function: comparison with B-type natriuretic peptide measurement.
    Arques S; Roux E; Sbragia P; Ambrosi P; Taieb L; Pieri B; Gelisse R; Luccioni R
    Echocardiography; 2005 Sep; 22(8):657-64. PubMed ID: 16174119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.